December 20, 2020
Article
Dr. Gregory Weiss offers perspective on a recent guideline update from the American Heart Association outlining strategies to best manage risk of cardiovascular disease in women entering menopause.
November 21, 2020
Article
In a recent column Gregory Weiss, MD, uses studies from AHA Scientific Sessions 2020 to compare the cost-effectiveness of antihyperglycemic agents for reducing cardiovascular events.
April 20, 2018
Article
Empagliflozin shown to significantly reduce liver fat in patients with T2DM, according to a new study.